Gene: FRYL
Official Full Name: FRY like transcription coactivatorprovided by HGNC
Gene Summary: Predicted to be involved in cell morphogenesis and neuron projection development. Predicted to be active in cell cortex and site of polarized growth. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29980 | FRYL Knockout cell line (HeLa) | Human | FRYL | 1:3~1:6 | Negative | Online Inquiry |
KO29981 | FRYL Knockout cell line (HCT 116) | Human | FRYL | 1:2~1:4 | Negative | Online Inquiry |
KO29982 | FRYL Knockout cell line (HEK293) | Human | FRYL | 1:3~1:6 | Negative | Online Inquiry |
KO29983 | FRYL Knockout cell line (A549) | Human | FRYL | 1:3~1:4 | Negative | Online Inquiry |
FRYL Gene Knockout Cell Lines are meticulously engineered cellular models designed for the functional study of the FRYL gene, which plays a crucial role in developmental biology and various disease processes. These cell lines are generated using advanced CRISPR-Cas9 technology that enables precise editing of the genomic DNA, facilitating the complete knockout of the FRYL gene. The resulting cell lines provide researchers with an invaluable tool to dissect the gene's biological significance and its implications in pathological conditions.
The principal function of the FRYL Gene Knockout Cell Lines is to enable the study of gene function and its regulatory pathways under various physiological and pathological conditions. By eliminating the expression of the FRYL gene, researchers can observe changes in cellular behavior, signaling pathways, and gene networks, thereby providing insights into its role in cellular homeostasis and disease mechanisms. The ability to model diseases and screen potential therapeutic compounds using these cell lines enhances their relevance in translational research.
In addition to being essential for fundamental research, these knockout cell lines are pertinent in the development of targeted therapies and novel diagnostics, making them a critical asset in both academic and clinical settings. The unique selling point of the FRYL Gene Knockout Cell Lines lies in their robustness and reproducibility, combined with the precise genetic modifications achieved through the CRISPR-Cas9 method, offering a level of specificity that is often unattainable with traditional methods.
Moreover, these cell lines provide significant advantages over alternatives, such as non-specific knockdown methods, by ensuring a complete loss of function, which is vital for accurately assessing the biological role of the FRYL gene. Researchers and clinicians will find these cell lines a valuable addition to their experimental repertoire, as they facilitate a deeper understanding of genetic contributions to diseases and aid in the identification of viable therapeutic targets.
Our company specializes in providing high-quality biological products, including gene-edited cell lines, backed by years of expertise and a commitment to advancing scientific discovery. By choosing FRYL Gene Knockout Cell Lines, users are assured reliable models that enhance research productivity and contribute to innovative breakthroughs in understanding gene function and disease mechanisms.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.